Clinical Trials

Breast Neoplasms

NCT00106691 2023-06-12

Prostate Cancer Prevention Study for Men With High Grade PIN (Prostatic Intraepithelial Neoplasia)

GenitourinaryOther neoplasm

1,589 enrolled 16 charts

Neoplasms, Precancerous Conditions, Prostatic Intraepithelial Neoplasia

NCT05801705 2023-05-18

Comparative Evaluation of Efficacy and Safety of Toremifene, Tamoxifen, and Aromatase Inhibitor Plus Ovarian Function Suppression in Hormone Receptor-Positive Early Breast Cancer Among Non-Low-Risk Premenopausal Women: A Real-World Study

Unknown

700 enrolled

Hormone-receptor-positive Breast Cancer

NCT04666805 2020-12-14

Effect of Endocrine Therapy Duration on Clinical Outcome of Patients With HR+ Intraductal Carcinoma of the Breast

Unknown

1,354 enrolled

Breast Neoplasms, Neoplasm Metastasis, Recurrence

NCT02344940 2019-09-24

TTOS

Phase 4 Completed

104 enrolled

Breast Neoplasms

NCT02506790 2019-09-04

Neoadjuvant Toremifene With Melatonin or Metformin in Locally Advanced Breast Cancer

Phase 2 Unknown

96 enrolled

Breast Neoplasms

NCT03925233 2019-04-24

Breast Cancer Treatment Based on Organ-like Culture

Unknown

300 enrolled

Breast Cancer Organoids

NCT03238703 2018-12-27

Endocrine Therapy in Treating Patients With HER2 Negative, Low Risk Breast Cancer

Phase 4 Withdrawn

Breast Carcinoma In Situ, Breast Neoplasms

NCT03351062 2017-11-22

Efficacy of Tamoxifen Versus Toremifene in CYP2D6 IM/PM of Premenopausal Patients With ER-positive Early Breast Cancer

Phase 3 Unknown

844 enrolled

Breast Neoplasms

NCT00003865 2017-07-13

Toremifene in Treating Patients With Ovarian Cancer

Phase 2 Withdrawn

Gynecologic

Carcinoma, Ovarian Epithelial, Ovarian Neoplasms

NCT02089854 2016-12-02

AETNBC

Phase 4 Unknown

800 enrolled

Triple Negative Breast Neoplasms

NCT02097459 2016-05-25

Prognostic Evaluation of Changing Endocrine Therapy in Women With Breast Cancer

Phase 3 Unknown

600 enrolled

Breast Neoplasms

NCT00020735 2015-12-02

Toremifene Followed by Radical Prostatectomy in Treating Patients With Stage I or Stage II Prostate Cancer

Phase 2 Completed

45 enrolled

Prostatic Neoplasms

NCT00044291 2015-07-31

Phase III Study of Atamestane Plus Toremifene Versus Letrozole in Advanced Breast Cancer

865 enrolled

Breast Neoplasms, Neoplasms, Hormone-Dependent, Carcinoma, Ductal, Breast, Carcinoma, Lobular

NCT02353429 2015-02-02

Toremifene in Desmoid Tumor: Prospective Clinical Trial and Identification of Potential Molecular Targets

Phase 2 Unknown

25 enrolled

Sarcoma

Desmoid Tumors

NCT02132390 2014-06-04

Adjuvant Toremifene With or Without Goserrelin in Premenopausal Women With Stage I-IIIA, Hormonal Receptor Positive Breast Cancer Accompanied With or Without Chemotherapy Induced Amenorrhoea

Phase 3 Unknown

300 enrolled

Breast Neoplasms

NCT02132000 2014-05-06

Efficacy and Tolerability of Toremifene or Tamoxifen Therapy in Premenopausal Estrogen and Progesterone Receptor Positive Breast Cancer Patients

Phase 2/3 Unknown

3,036 enrolled

Breast Cancer Patients in Premenopausal

NCT00010322 2014-03-26

Toremifene With or Without Atamestane in Treating Postmenopausal Women With Metastatic Breast Cancer

Phase 3 Terminated

Breast Neoplasms

NCT00028353 2013-11-15

A Chemoprevention Study of an Investigational Drug in Men With High Grade Prostate Intraepithelial Neoplasia (PIN)

Phase 2 Completed

500 enrolled

Prostatic Intraepithelial Neoplasia

NCT00129142 2013-11-15

Toremifene Citrate for Prevention of Bone Fractures in Men With Prostate Cancer on Androgen Deprivation Therapy

1,200 enrolled

Bone Diseases, Metabolic, Osteoporosis, Prostatic Neoplasms, Fractures, Bone

NCT01214291 2013-11-15

TREAT2

Phase 3 Withdrawn

Prostatic Neoplasms, Fractures, Bone

NCT00002595 2013-07-10

Toremifene in Treating Patients With Desmoid Tumors

Phase 2 Completed

72 enrolled

Sarcoma

Desmoid Tumors

NCT00002529 2013-04-04

12-93

452 enrolled

Breast Neoplasms

NCT00437359 2012-03-30

Antiestrogen vs Aromatase Inhibitor After Adjuvant Chemotherapy for Breast Cancer

Phase 2 Terminated

240 enrolled

Breast Neoplasms

NCT00267553 2007-09-10

Treatment and Survival Continuation Study of Atamestane Plus Toremifene vs Letrozole in Advanced Breast Cancer

Phase 3 Terminated

200 enrolled

Breast Neoplasms, Neoplasms, Hormone-Dependent, Carcinoma, Ductal, Breast, Carcinoma, Lobular

NCT00097344 2007-08-23

The CAT Study: Atamestane Plus Toremifene Versus Letrozole in Advanced Breast Cancer

Phase 3 Terminated

842 enrolled